rfhg_77851.1

Basic information about the TSS

---

TSS ID: rfhg_77851.1 Species: human Chr: chr6		Start: 10723399 End: 10723401 Strand: +
Source datasets	PRJNA4843412
Protocol	NETCAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS (EH38D3812264,EH38E2445313)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK223462:-182 GeneID: 51522 HGNC/MGI_ID: HGNC:20952 UniProt_ID: Q53F27 Nearer transcript ids and distances:

Gene_name: TMEM14C Gene_symbol: TMEM14C Gene_synonyms: HSPC194 NET26 bA421M1.6 Gene_source: HGNC:20952

TATA-Box annotation

---

Distance to TSS:	330
Nearest PromoterID:	NM_016462
Entrez ID:	51522
Nearest Unigene:	Hs.519557
Nearest Refseq:	NM_016462
Nearest Ensembl:	ENSG00000111843
Gene Name:	TMEM14C
Gene Alias:	C6orf53|HSPC194|MSTP073|NET26|bA421M1.6
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.333333
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TMEM14C p2@TMEM14C p3@TMEM14C
Sample		p1@TMEM14C	p2@TMEM14C	p3@TMEM14C
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	74.22	26.88	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	82.14	30.35	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	92.59	34.92	1.16
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	70.69	27.03	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	80.09	34.19	1.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	80.82	37.79	2.91
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	105.67	48.81	1.96
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	91.07	38.76	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	85.49	31.20	1.71
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	84.05	27.24	2.90
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	62.66	24.66	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	73.18	25.21	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	193.11	45.78	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	191.25	53.07	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	158.74	41.50	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	179.31	46.27	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	179.75	48.92	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	214.28	51.46	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	189.27	44.78	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	185.04	43.78	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	194.73	51.32	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	199.38	48.68	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	180.83	47.95	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	180.54	53.87	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	187.30	50.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	210.16	60.14	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	209.89	52.20	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	198.50	50.45	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	206.43	44.58	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	186.58	51.76	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	205.58	52.13	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	201.83	49.24	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	244.16	53.39	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	323.78	79.67	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	192.97	51.42	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	203.70	41.01	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	222.77	50.89	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	207.73	51.18	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	208.52	52.40	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	182.93	47.77	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	206.56	54.82	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	259.56	70.71	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	182.42	43.02	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	205.95	48.25	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	185.92	52.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	191.24	47.69	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	191.93	44.62	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	181.21	54.25	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	208.97	44.04	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	198.36	44.69	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	184.46	37.92	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	207.92	52.26	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	503.72	265.85	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	176.36	44.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	215.07	47.06	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	386.75	236.58	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	258.09	95.06	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	176.64	35.98	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	178.57	43.04	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	221.92	82.35	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	180.49	42.30	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	191.23	34.77	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	197.44	83.59	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	185.17	65.58	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	145.89	38.02	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	162.23	46.50	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	307.11	161.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	434.36	300.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	172.58	64.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	176.53	62.48	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	170.76	60.98	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	149.37	87.77	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	159.62	70.22	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	137.89	67.26	0.31
Adipocyte - breast, donor1	11376-118A8	230.92	94.56	1.27
Adipocyte - breast, donor2	11327-117E4	156.26	55.83	0.64
Adipocyte - omental, donor1	11473-119C6	222.14	75.06	1.27
Adipocyte - omental, donor2	11474-119C7	175.66	64.28	1.49
Adipocyte - omental, donor3	11475-119C8	173.49	55.60	0.67
Adipocyte - perirenal, donor1	11476-119C9	211.81	76.56	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	98.96	16.49	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	153.10	44.26	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	160.74	28.50	1.22
Adipocyte differentiation, day04, donor1	13019-139D4	128.30	41.66	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	96.00	24.19	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	114.30	36.24	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	106.39	27.63	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	132.71	38.61	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	107.80	25.17	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	106.64	29.33	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	92.37	27.82	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	177.59	40.34	1.66
Adipocyte differentiation, day12, donor2	13024-139D9	114.28	35.41	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	128.61	36.32	1.31
Adipocyte differentiation, day12, donor4	13030-139E6	82.82	20.10	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	186.08	73.59	1.33
Alveolar Epithelial Cells, donor2	11590-120G6	152.76	22.23	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	143.76	26.36	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	200.59	81.14	3.60
Amniotic Epithelial Cells, donor2	11613-122A2	184.08	46.86	6.69
Amniotic Epithelial Cells, donor3	11694-123A2	161.07	55.06	1.64
Anulus Pulposus Cell, donor1	11248-116E6	240.07	50.81	0.92
Anulus Pulposus Cell, donor2	11463-119B5	147.92	24.98	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	156.80	29.20	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	178.00	46.89	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	128.41	40.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	140.79	37.37	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	142.91	45.53	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	149.84	23.76	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	147.50	37.36	1.62
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	150.97	41.26	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	153.22	33.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	158.94	40.68	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	169.08	37.74	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	134.15	32.60	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	192.91	52.72	0.99
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	185.61	25.93	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	159.08	42.37	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	165.02	39.65	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	150.58	36.84	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	153.96	35.55	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	163.88	32.19	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	132.36	31.18	1.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	142.89	43.23	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	145.15	35.40	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	130.02	36.88	1.37
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	171.99	54.53	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	163.10	45.14	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	140.02	45.53	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	175.65	23.02	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	162.46	45.03	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	152.42	34.63	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	138.59	32.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	157.65	42.23	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	141.48	28.30	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	151.97	32.11	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	153.84	43.87	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	135.18	35.83	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	163.94	36.83	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	152.57	44.75	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	146.95	38.71	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	134.70	29.86	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	164.41	32.37	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	150.72	34.93	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	140.06	25.23	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	160.61	29.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	135.45	37.30	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	134.35	67.17	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	169.01	54.93	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	142.58	33.66	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	147.41	37.90	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	178.60	43.01	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	146.66	40.92	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	165.77	45.91	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	181.78	47.80	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	160.82	35.71	1.45
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	141.37	31.21	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	158.22	36.81	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	143.91	36.37	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	135.80	32.04	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	145.12	43.20	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	120.22	27.80	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	135.57	30.89	0.36
Astrocyte - cerebellum, donor1	11500-119F6	230.77	56.37	2.95
Astrocyte - cerebellum, donor2	11580-120F5	187.08	40.39	2.23
Astrocyte - cerebellum, donor3	11661-122F5	164.44	28.32	3.78
Astrocyte - cerebral cortex, donor1	11235-116D2	131.07	63.44	2.09
Astrocyte - cerebral cortex, donor2	11316-117D2	113.08	49.50	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	123.80	59.51	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	83.03	45.30	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	84.19	49.24	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	73.06	42.10	0.68
Basophils, donor1	12241-129G9	46.55	13.60	1.31
Basophils, donor2	12242-129H1	38.97	19.12	0.00
Basophils, donor3	12243-129H2	47.48	10.44	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	143.59	64.25	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	63.55	11.89	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	78.91	86.08	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	86.62	29.50	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	82.14	23.29	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	110.54	32.24	2.07
Bronchial Epithelial Cell, donor7	11769-123I5	117.14	66.94	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	135.72	106.56	3.19
Burkitt's lymphoma cell line:RAJI	10476-106I8	82.22	72.67	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	196.02	100.09	4.16
CD133+ stem cells - cord blood derived, pool1	12223-129E9	175.81	93.08	0.00
CD14+ Monocytes, donor1	11224-116B9	49.03	11.27	0.56
CD14+ Monocytes, donor2	11305-117B9	31.92	5.20	0.56
CD14+ Monocytes, donor3	11381-118B4	41.71	11.64	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	170.11	55.76	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	166.79	54.59	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	165.36	47.67	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	35.13	9.68	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	35.61	5.13	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	23.69	6.40	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	20.76	4.18	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	25.67	4.14	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	24.05	7.93	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	25.85	4.70	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	32.23	5.52	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	46.14	13.49	1.52
CD14+ monocytes - treated with Candida, donor1	11868-125B5	28.80	5.38	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	46.99	6.34	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	44.37	8.87	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	32.28	7.14	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	30.73	5.99	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	41.22	11.45	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	26.08	5.26	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	32.12	8.37	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	21.39	2.18	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	24.75	6.46	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	41.00	8.20	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	33.24	10.52	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	23.51	4.96	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	19.73	2.47	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	14.92	5.70	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	27.55	5.23	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	33.82	6.69	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	50.01	13.15	1.08
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	23.34	6.14	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	28.74	5.33	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	29.69	5.57	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	119.88	31.60	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	95.17	28.18	1.85
CD14+CD16+ Monocytes, donor3	11912-125G4	112.42	33.79	1.73
CD14+CD16- Monocytes, donor1	11788-124B6	141.08	45.16	1.87
CD14+CD16- Monocytes, donor2	11799-124C8	112.12	36.85	1.75
CD14+CD16- Monocytes, donor3	11910-125G2	92.09	26.76	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	153.36	39.30	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	98.80	27.23	2.42
CD14-CD16+ Monocytes, donor3	11911-125G3	110.96	23.79	1.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	85.36	71.13	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	76.61	41.36	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	79.74	38.32	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	83.69	55.97	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	94.88	56.29	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	80.02	54.75	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	90.99	40.79	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	84.37	48.78	0.00
CD19+ B Cells, donor1	11544-120B5	29.59	5.75	0.00
CD19+ B Cells, donor2	11624-122B4	18.86	5.08	0.73
CD19+ B Cells, donor3	11705-123B4	22.21	10.10	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	944.69	320.42	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	866.10	283.24	0.40
CD34+ Progenitors, donor1	11545-120B6	118.48	53.21	4.02
CD34+ Progenitors, donor2	11625-122B5	86.52	28.09	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	232.97	111.22	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	289.75	169.79	2.03
CD4+ T Cells, donor1	11225-116C1	35.71	9.64	0.36
CD4+ T Cells, donor2	11306-117C1	27.56	11.02	0.00
CD4+ T Cells, donor3	11382-118B5	37.21	16.16	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	78.10	46.20	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	79.06	52.56	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	81.06	45.42	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	79.17	41.72	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	83.58	54.08	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	92.29	32.96	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	88.73	48.27	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	67.11	30.16	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	57.87	28.53	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	78.45	34.97	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	98.88	38.08	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	88.44	29.92	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	74.21	65.35	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	61.71	43.01	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	61.15	40.43	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	68.26	53.30	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	83.61	57.35	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	52.00	44.83	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	67.87	53.40	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	68.67	47.66	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	63.68	30.68	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	81.40	50.56	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	87.08	60.22	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	66.68	47.07	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	93.53	44.04	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	80.32	31.39	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	93.52	36.29	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	105.79	50.68	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	97.67	52.02	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	84.70	27.72	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	82.01	30.44	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	83.10	41.55	0.00
CD8+ T Cells, donor1	11226-116C2	30.12	11.13	0.00
CD8+ T Cells, donor2	11307-117C2	13.52	3.38	0.00
CD8+ T Cells, donor3	11383-118B6	20.70	7.83	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	53.22	35.79	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	52.48	33.55	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	55.81	42.13	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	70.25	44.43	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	58.56	33.84	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	53.89	32.06	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	53.89	40.20	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	56.33	34.48	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	49.95	35.88	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	70.64	54.04	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	67.40	41.54	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	63.41	49.29	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	38.08	23.20	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	34.61	25.05	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	22.38	12.68	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	52.58	39.98	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	50.06	37.69	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	45.96	28.05	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	51.02	44.05	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	60.90	37.83	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	58.35	33.34	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	60.81	48.19	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	53.99	33.89	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	53.71	43.87	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	45.77	23.29	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	56.65	39.17	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	41.07	27.05	0.00
Cardiac Myocyte, donor1	11525-119I4	69.45	12.79	0.00
Cardiac Myocyte, donor2	11605-120I3	154.16	37.55	0.49
Cardiac Myocyte, donor3	11686-122I3	201.94	63.35	0.84
Chondrocyte - de diff, donor1	11261-116G1	183.04	49.92	0.35
Chondrocyte - de diff, donor2	11338-117F6	148.90	31.63	3.55
Chondrocyte - de diff, donor3	11410-118E6	190.12	40.85	0.57
Chondrocyte - re diff, donor2	11339-117F7	214.86	51.03	2.69
Chondrocyte - re diff, donor3	11411-118E7	135.88	40.04	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	212.07	69.43	2.30
Ciliary Epithelial Cells, donor2	11323-117D9	144.29	42.97	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	146.46	45.22	2.30
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	112.15	32.74	3.03
Corneal Epithelial Cells, donor1	11526-119I5	188.83	68.95	0.44
Corneal Epithelial Cells, donor2	11606-120I4	102.38	38.68	0.00
Corneal Epithelial Cells, donor3	11687-122I4	136.25	49.85	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	130.59	47.71	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	139.10	45.42	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	213.94	86.27	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	111.77	44.49	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	95.66	58.42	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	132.53	88.79	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	122.92	66.30	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	86.22	48.70	1.67
Endothelial Cells - Aortic, donor1	11263-116G3	92.71	13.50	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	75.79	17.82	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	92.01	11.01	0.39
Endothelial Cells - Artery, donor1	11264-116G4	95.70	18.62	0.29
Endothelial Cells - Artery, donor2	11341-117F9	57.88	11.76	0.47
Endothelial Cells - Artery, donor3	11413-118E9	92.39	17.53	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	162.91	37.90	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	174.95	37.12	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	117.84	26.78	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	152.13	32.09	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	179.63	28.64	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	108.04	15.60	2.27
Endothelial Cells - Thoracic, donor1	11266-116G6	132.84	42.81	2.00
Endothelial Cells - Thoracic, donor2	11343-117G2	109.02	21.49	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	125.24	32.80	1.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	45.41	11.51	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	46.65	14.29	0.37
Endothelial Cells - Vein, donor1	11267-116G7	61.43	14.79	1.14
Endothelial Cells - Vein, donor2	11344-117G3	101.98	20.96	0.70
Endothelial Cells - Vein, donor3	11416-118F3	84.47	24.96	1.26
Eosinophils, donor1	12244-129H3	60.99	15.25	0.00
Eosinophils, donor2	12245-129H4	4.95	0.00	0.00
Eosinophils, donor3	12246-129H5	17.83	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	151.73	70.85	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	118.57	43.68	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	65.08	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	133.42	36.54	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	145.73	37.66	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	84.18	49.29	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	176.34	59.18	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	152.03	37.12	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	193.75	44.19	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	96.70	67.72	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	94.01	55.48	0.33
Fibroblast - Cardiac, donor1	11268-116G8	151.06	44.46	0.45
Fibroblast - Cardiac, donor2	11345-117G4	79.58	21.98	0.00
Fibroblast - Cardiac, donor3	11417-118F4	113.71	31.70	0.63
Fibroblast - Cardiac, donor4	11452-119A3	138.52	37.89	0.30
Fibroblast - Cardiac, donor5	11456-119A7	127.28	31.98	0.76
Fibroblast - Cardiac, donor6	11460-119B2	106.27	30.77	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	249.62	58.29	1.88
Fibroblast - Choroid Plexus, donor2	11572-120E6	129.43	24.59	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	123.04	36.62	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	246.32	69.42	3.46
Fibroblast - Conjunctival, donor3	11692-122I9	209.46	54.10	2.37
Fibroblast - Dermal, donor1	11269-116G9	173.50	35.69	0.70
Fibroblast - Dermal, donor2	11346-117G5	159.90	37.73	0.94
Fibroblast - Dermal, donor3	11418-118F5	179.64	40.98	0.60
Fibroblast - Dermal, donor4	11450-119A1	98.69	31.65	0.23
Fibroblast - Dermal, donor5	11454-119A5	107.46	30.35	0.70
Fibroblast - Dermal, donor6	11458-119A9	91.44	36.06	0.65
Fibroblast - Gingival, donor1	11237-116D4	124.52	42.90	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	166.11	45.06	1.31
Fibroblast - Gingival, donor2	11318-117D4	132.71	43.75	0.66
Fibroblast - Gingival, donor3	11394-118C8	110.61	26.88	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	153.76	37.40	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	106.60	27.49	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	130.33	52.85	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	126.98	48.68	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	24.00	7.41	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	112.61	36.85	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	134.04	50.86	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	98.07	39.27	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	112.40	27.00	0.73
Fibroblast - Lung, donor1	11270-116H1	77.48	9.52	1.36
Fibroblast - Lung, donor2	11347-117G6	131.31	40.29	1.49
Fibroblast - Lung, donor3	11419-118F6	103.62	36.51	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	358.20	69.14	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	179.02	33.57	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	136.86	17.07	0.28
Fibroblast - Mammary, donor1	11540-120B1	215.57	66.98	1.62
Fibroblast - Mammary, donor2	11620-122A9	227.67	27.96	0.00
Fibroblast - Mammary, donor3	11701-123A9	148.91	11.91	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	146.64	67.70	0.97
Fibroblast - Periodontal Ligament, donor2	11319-117D5	107.54	34.43	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	101.59	38.86	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	85.48	28.62	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	132.57	47.79	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	84.55	25.51	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	168.34	71.40	1.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	203.19	63.40	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	165.71	46.77	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	158.94	61.68	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	96.45	21.04	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	188.99	51.33	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	201.03	56.17	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	103.19	26.17	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	206.62	62.40	1.08
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	109.83	27.59	0.51
Fibroblast - skin normal, donor1	11553-120C5	217.57	62.51	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	74.19	31.68	1.60
Fibroblast - skin normal, donor2	11561-120D4	166.06	54.75	1.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	101.25	31.13	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	235.45	62.80	1.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	260.19	54.88	1.03
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	114.62	20.36	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	149.66	49.32	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	151.81	60.73	1.01
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	213.43	110.09	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	177.28	421.04	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	58.39	23.53	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	205.08	90.84	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	157.45	73.13	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	139.00	66.94	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	189.86	71.20	8.42
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	223.96	103.37	10.85
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	83.87	130.94	6.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	88.24	121.33	5.24
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	91.79	57.77	3.42
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	77.47	83.21	4.76
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	76.92	127.94	3.44
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	81.54	56.10	3.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	112.77	92.87	3.54
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	146.69	64.73	4.24
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	142.60	60.83	4.06
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	135.66	56.14	4.57
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	152.88	56.37	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	163.90	60.91	2.08
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	138.86	51.44	3.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	149.91	53.39	2.51
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	141.01	59.04	1.74
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	134.64	45.25	1.97
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	153.35	58.80	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	135.11	50.55	1.91
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	136.51	50.72	1.56
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	111.70	43.96	1.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	122.65	53.27	2.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	176.81	57.55	3.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	191.67	69.93	2.91
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	183.58	65.58	1.54
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	118.18	46.70	1.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	156.24	60.73	2.16
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	145.38	61.25	2.86
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	128.53	54.88	1.86
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	123.59	49.58	2.42
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	100.23	35.02	2.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	130.72	45.85	2.20
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	139.60	59.90	1.11
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	111.68	36.47	3.24
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	150.09	60.62	1.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	106.31	35.63	2.27
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	92.85	32.43	1.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	117.07	48.65	2.43
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	102.76	39.93	1.36
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	106.92	34.91	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	111.66	45.17	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	89.07	24.26	0.83
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	111.77	36.63	1.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	89.20	26.62	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	93.66	26.81	1.04
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	116.29	38.49	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	115.96	33.74	1.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	119.96	31.14	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	86.28	17.85	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	128.35	25.72	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	122.47	23.40	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	150.97	36.60	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	152.48	82.21	4.38
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	134.35	70.72	2.47
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	132.57	68.74	5.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	244.40	93.88	5.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	239.32	111.61	8.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	158.19	65.95	5.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	249.95	64.34	19.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	184.51	67.69	6.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	247.09	77.01	6.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	168.67	48.69	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	187.80	60.54	9.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	195.19	50.65	9.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	129.96	43.32	10.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	197.99	59.29	8.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	200.68	56.22	6.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	163.57	36.91	5.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	224.24	71.57	10.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	209.91	55.70	6.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	292.34	104.41	8.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	269.74	91.63	3.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	213.11	55.94	5.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	286.31	84.71	8.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	278.35	62.96	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	209.19	61.44	7.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	305.57	115.91	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	222.57	65.73	7.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	287.51	60.63	3.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	367.19	88.96	3.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	318.62	91.69	9.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	270.11	72.58	6.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	293.20	91.94	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	283.58	72.19	5.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	324.08	71.82	8.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	295.03	77.83	6.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	291.95	71.39	4.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	293.55	74.50	5.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	275.04	72.01	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	359.99	93.93	4.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	274.74	70.22	2.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	234.81	54.25	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	229.22	66.85	7.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	236.80	69.39	3.40
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	120.98	37.66	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	97.72	16.63	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	120.32	30.36	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	200.45	36.16	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	229.76	40.10	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	353.35	168.38	4.29
Hep-2 cells mock treated, biol_rep2	11899-125E9	350.60	159.18	4.05
Hep-2 cells mock treated, biol_rep3	11900-125F1	314.86	158.34	6.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	337.00	154.34	3.94
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	341.07	159.68	4.73
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	297.52	144.45	6.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	374.98	162.15	4.23
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	320.80	160.74	4.63
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	304.35	139.36	4.16
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	114.72	23.50	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	106.03	23.80	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	103.11	21.15	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	227.15	53.61	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	202.70	24.70	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	127.63	52.45	1.05
Hepatocyte, donor1	11523-119I2	96.85	44.79	0.00
Hepatocyte, donor2	11603-120I1	79.72	34.47	0.00
Hepatocyte, donor3	11684-122I1	66.26	20.25	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	93.99	107.69	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	165.34	78.65	1.92
Iris Pigment Epithelial Cells, donor1	11530-119I9	137.89	42.81	1.23
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	98.70	44.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	100.13	46.73	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	74.76	29.07	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	100.11	27.53	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	118.68	47.47	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	84.58	23.07	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	54.85	9.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	100.71	43.86	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	105.04	36.68	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	112.55	39.94	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	90.00	33.09	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	114.19	70.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	83.81	57.62	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	124.71	49.76	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	100.53	41.76	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	73.17	43.90	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	89.80	37.47	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	96.60	32.20	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	143.38	71.69	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	114.90	33.41	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	102.43	50.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	86.23	28.74	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	116.53	45.01	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	100.64	47.09	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	128.39	60.42	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	103.40	54.42	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	44.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	100.08	52.73	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	91.47	38.11	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	82.15	32.86	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	97.56	37.62	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	60.15	23.69	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	94.83	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	78.55	36.42	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	82.96	19.91	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	104.24	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	137.35	60.81	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	93.07	47.41	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	106.87	37.72	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	89.01	28.51	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	119.51	59.75	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	162.10	42.15	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	106.38	38.36	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	103.49	47.25	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	135.90	31.36	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	102.41	46.94	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	74.81	27.71	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	85.49	39.89	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	89.28	48.78	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	105.89	51.43	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	111.76	43.46	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	116.31	57.10	1.06
Keratinocyte - epidermal, donor1	11272-116H3	102.73	36.72	0.16
Keratinocyte - epidermal, donor2	11349-117G8	74.96	30.45	0.00
Keratinocyte - epidermal, donor3	11421-118F8	142.55	74.02	0.38
Keratinocyte - oral, donor1	11251-116E9	225.79	145.53	0.34
Keratocytes, donor1	11527-119I6	228.30	83.89	1.72
Keratocytes, donor2	11607-120I5	111.32	30.47	0.00
Keratocytes, donor3	11688-122I5	106.11	33.39	0.99
Krukenberg tumor cell line:HSKTC	10687-109F3	43.96	15.39	0.00
Lens Epithelial Cells, donor1	11529-119I8	158.58	48.54	0.00
Lens Epithelial Cells, donor2	11609-120I7	159.85	70.24	1.73
Lens Epithelial Cells, donor3	11690-122I7	157.52	41.68	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	162.09	45.77	1.07
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	115.54	48.28	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	129.86	33.84	1.57
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	128.51	33.88	3.23
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	96.44	38.14	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	133.58	36.01	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	133.38	29.14	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	127.67	62.95	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	115.27	33.78	1.41
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	127.76	39.55	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	114.97	53.12	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	136.08	34.25	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	145.64	45.99	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	113.06	55.58	1.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	130.34	33.51	1.79
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	137.35	40.34	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	120.64	58.61	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	134.13	33.30	1.28
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	139.87	42.13	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	114.51	53.60	1.76
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	122.22	27.38	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	123.18	38.80	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	105.29	52.51	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	125.19	31.18	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	129.60	39.92	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	101.76	46.90	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	119.70	27.67	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	134.82	30.27	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	108.37	53.81	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	122.78	35.10	1.27
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	121.14	33.92	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	103.87	50.61	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	123.52	27.50	1.36
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	136.24	31.84	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	112.18	53.12	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	127.87	30.52	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	126.40	30.56	1.93
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	99.21	50.21	1.83
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	132.13	33.17	2.10
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	124.09	44.80	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	125.07	47.51	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	108.93	29.10	1.56
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	137.51	39.75	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	99.96	47.37	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	123.13	24.72	1.65
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	140.58	40.71	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	84.27	45.33	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	112.78	32.22	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	163.15	40.79	6.80
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	141.15	31.45	6.14
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	133.60	29.69	3.71
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	127.78	22.00	4.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	128.00	22.51	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	121.42	29.89	3.74
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	104.08	14.43	5.67
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	96.35	27.36	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	144.31	29.63	2.71
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	136.98	33.74	2.91
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	158.46	42.32	3.60
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	147.41	35.77	4.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	121.19	27.22	4.11
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	141.49	31.05	6.70
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	136.59	31.32	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	120.22	31.58	2.55
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	152.08	31.22	6.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	125.84	31.18	4.16
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	130.08	26.38	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	123.94	26.09	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	127.65	31.44	5.41
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	136.21	31.39	4.76
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	139.10	29.88	4.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	126.28	30.77	3.19
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	144.08	35.57	3.59
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	141.08	31.54	2.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	119.13	24.39	4.60
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	142.35	28.03	5.53
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	128.94	20.72	8.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	132.01	25.33	6.14
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	121.72	26.04	7.36
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	128.81	28.72	4.10
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	128.79	24.40	4.07
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	133.57	25.14	5.03
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	147.89	21.66	5.98
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	125.97	21.55	3.34
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	141.72	22.83	5.17
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	123.31	23.98	5.14
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	128.61	28.65	5.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	132.73	15.08	3.02
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	115.89	17.77	4.98
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	117.90	24.40	2.75
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	117.55	24.15	4.29
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	126.59	22.89	3.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	122.98	29.63	3.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	182.58	32.56	4.65
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	110.01	23.27	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	114.44	22.01	2.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	114.85	21.08	3.63
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	124.94	17.63	3.07
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	119.87	24.66	3.95
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	118.56	23.52	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	145.32	18.10	7.04
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	112.66	23.88	3.60
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	115.31	25.82	6.88
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	123.36	27.17	5.79
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	125.91	23.46	2.35
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	118.09	19.13	3.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	118.32	23.87	3.63
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	127.77	21.88	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	119.65	24.04	3.35
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	112.62	31.80	4.86
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	126.13	21.99	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	121.02	19.75	4.05
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	116.79	20.67	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	114.49	23.06	2.78
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	122.74	20.05	4.86
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	134.19	22.83	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	124.64	26.98	4.18
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	115.16	17.56	5.68
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	115.49	24.19	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	131.83	26.62	4.12
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	123.14	18.66	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	137.35	24.71	5.17
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	122.39	20.57	4.11
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	135.10	19.10	4.95
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	132.79	27.24	5.67
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	123.14	24.13	4.16
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	138.60	18.01	3.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	141.55	23.80	5.85
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	117.09	26.95	5.58
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	112.40	22.75	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	155.05	27.27	3.21
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	129.31	26.67	4.04
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	110.13	19.27	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	149.37	35.56	3.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	123.09	21.09	2.85
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	126.54	24.54	3.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	135.15	30.64	4.38
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	110.92	22.27	3.12
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	150.77	30.15	3.38
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	151.85	34.48	6.63
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	116.40	29.10	8.31
Macrophage - monocyte derived, donor1	11232-116C8	141.08	46.95	0.00
Macrophage - monocyte derived, donor2	11313-117C8	132.68	53.58	0.00
Macrophage - monocyte derived, donor3	11389-118C3	110.24	39.06	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	278.26	139.66	0.53
Mallassez-derived cells, donor2	11929-125I3	199.02	125.81	0.32
Mallassez-derived cells, donor3	11930-125I4	168.59	99.65	0.69
Mammary Epithelial Cell, donor1	11273-116H4	131.63	121.86	1.40
Mammary Epithelial Cell, donor2	11350-117G9	131.75	86.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	66.85	29.68	0.25
Mast cell - stimulated, donor1	11487-119E2	185.75	75.93	2.03
Mast cell, donor1	11563-120D6	115.93	52.02	1.41
Mast cell, donor2	11565-120D8	122.44	43.68	2.97
Mast cell, donor3	11566-120D9	134.85	40.30	2.25
Mast cell, donor4	11567-120E1	158.14	52.83	1.77
Mast cell, expanded and stimulated, donor5	11940-126A5	110.23	60.77	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	71.21	25.68	0.58
Mast cell, expanded, donor5	11939-126A4	177.70	69.41	0.57
Mast cell, expanded, donor8	11941-126A6	94.90	41.51	0.17
Melanocyte - dark, donor1	11502-119F8	166.66	46.47	1.59
Melanocyte - dark, donor2	11582-120F7	128.40	46.38	0.00
Melanocyte - dark, donor3	11663-122F7	130.90	57.37	0.51
Melanocyte - light, donor1	11274-116H5	74.28	23.98	0.47
Melanocyte - light, donor2	11351-117H1	67.56	12.28	0.68
Melanocyte - light, donor3	11423-118G1	68.51	13.88	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	100.59	42.27	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	158.41	42.22	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	117.32	46.34	0.27
Meningeal Cells, donor1	11493-119E8	286.95	76.79	2.61
Meningeal Cells, donor2	11573-120E7	168.14	55.90	0.88
Meningeal Cells, donor3	11654-122E7	197.89	69.19	1.39
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	171.38	88.40	1.71
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	239.50	53.74	1.21
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	101.19	13.14	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	96.80	20.93	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	113.38	37.32	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	222.36	63.32	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	167.88	51.77	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	172.73	59.99	1.54
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	108.13	54.06	4.38
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	136.27	34.17	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	281.72	50.28	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	170.25	27.51	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	197.36	103.29	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	190.80	32.94	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	65.40	4.67	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	162.02	56.36	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	136.11	54.94	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	174.81	104.14	1.25
Mesenchymal stem cells - umbilical, donor0	11214-116A8	134.98	62.41	2.18
Mesothelial Cells, donor1	11247-116E5	394.05	79.02	0.53
Mesothelial Cells, donor2	12156-128G5	347.32	67.06	1.00
Mesothelial Cells, donor3	11402-118D7	213.40	41.84	0.43
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	41.86	8.10	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	129.54	34.72	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	125.14	39.75	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	10.37	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	119.95	32.23	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	128.19	38.79	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	32.42	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	139.40	45.55	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	105.20	29.79	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	140.63	42.47	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	125.12	36.03	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	112.39	38.05	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	183.51	63.83	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	22.37	5.26	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	129.67	35.02	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	64.46	7.37	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	84.65	30.10	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	20.12	3.35	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	33.95	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	117.42	38.64	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	119.07	35.41	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	28.20	8.29	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	123.18	38.45	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	122.63	39.96	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	80.31	26.70	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	123.79	47.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	87.80	28.90	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	82.35	28.47	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	55.77	8.62	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	39.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	59.52	19.84	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	86.17	32.35	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	32.71	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	111.01	31.24	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	104.46	30.82	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	6.86	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	121.64	42.55	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	6.12	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	86.27	34.60	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	28.69	4.41	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	19.21	3.84	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	79.83	29.75	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	31.32	7.65	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	19.89	6.63	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	67.69	29.40	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	33.70	7.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	13.49	3.91	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	71.82	24.41	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	43.64	8.31	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	11.65	7.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	47.96	19.61	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	76.38	23.37	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	26.78	6.46	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	54.07	19.92	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	23.77	8.84	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	58.57	25.91	0.78
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	45.90	16.30	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	13.97	3.81	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	26.16	8.81	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	91.59	33.52	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	32.21	9.89	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	74.53	29.30	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	64.79	27.20	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	22.37	8.72	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	55.40	20.46	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	96.35	39.57	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	18.90	7.82	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	54.69	19.41	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	104.37	42.96	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	65.94	27.61	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	69.98	23.23	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	226.01	64.04	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	201.39	64.16	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	149.50	54.54	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	136.75	62.07	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	162.70	56.93	0.99
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	149.01	45.63	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	163.73	43.94	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	152.08	59.39	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	144.77	51.01	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	148.08	36.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	143.64	48.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	116.67	37.33	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	253.32	91.39	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	220.24	73.41	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	157.55	47.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	153.90	56.50	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	329.59	132.11	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	463.49	186.29	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	441.36	210.56	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	188.80	95.16	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	102.78	22.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	316.46	169.65	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	109.31	42.77	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	138.04	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	218.67	60.75	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	171.42	38.67	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	42.05	9.34	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	24.21	5.84	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	60.27	28.71	1.14
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	54.26	12.77	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	38.76	6.80	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	108.42	45.94	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	72.41	11.30	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	68.34	10.92	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	59.45	18.11	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	84.30	15.77	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	222.69	77.94	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	109.20	20.35	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	132.09	27.07	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	82.06	14.28	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	63.20	13.39	1.47
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	110.99	23.69	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	116.70	20.69	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	90.65	12.61	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	126.68	48.57	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	69.28	7.48	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	86.25	19.05	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	111.11	25.32	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	108.49	15.63	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	120.18	21.21	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	138.99	36.21	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	164.35	75.85	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	82.43	13.37	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	86.80	15.67	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	89.24	20.89	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	129.20	28.33	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	108.33	90.28	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	83.31	15.66	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	62.67	10.37	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	85.71	20.63	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	93.79	19.50	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	130.16	41.62	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	73.00	13.36	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	50.99	10.89	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	71.46	17.19	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	79.37	10.58	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	89.09	21.28	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	125.50	24.31	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	48.24	8.04	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	149.41	45.37	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	98.36	19.23	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	93.52	9.49	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	153.29	61.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	135.35	20.73	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	45.01	8.18	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	52.06	13.62	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	80.70	22.15	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	162.11	54.41	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	187.14	116.33	0.00
Myoblast, donor1	11241-116D8	140.63	43.73	1.12
Myoblast, donor2	11322-117D8	114.88	46.03	0.96
Myoblast, donor3	11398-118D3	171.86	49.27	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	13.13	9.49	0.00
Natural Killer Cells, donor1	11230-116C6	25.52	8.61	0.31
Natural Killer Cells, donor2	11311-117C6	10.55	2.11	0.00
Natural Killer Cells, donor3	11387-118C1	18.04	3.13	0.18
Neural stem cells, donor1	11275-116H6	152.07	47.18	7.26
Neural stem cells, donor2	11352-117H2	121.32	23.11	9.63
Neurons, donor1	11494-119E9	86.48	34.14	3.41
Neurons, donor2	11574-120E8	108.32	44.03	3.30
Neurons, donor3	11655-122E8	73.17	32.06	0.82
Neutrophils, donor1	11233-116C9	9.28	0.00	0.00
Neutrophils, donor2	11314-117C9	8.70	2.90	0.00
Neutrophils, donor3	11390-118C4	8.55	2.44	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	231.77	55.57	1.42
Nucleus Pulposus Cell, donor2	11409-118E5	139.68	24.09	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	171.27	25.07	0.80
Olfactory epithelial cells, donor1	11933-125I7	106.68	33.17	0.14
Olfactory epithelial cells, donor2	11934-125I8	136.06	37.49	0.43
Olfactory epithelial cells, donor3	11935-125I9	149.49	41.66	0.23
Olfactory epithelial cells, donor4	11936-126A1	137.82	32.82	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	134.21	84.86	0.60
Osteoblast - differentiated, donor1	11276-116H7	180.15	28.50	0.85
Osteoblast - differentiated, donor2	11353-117H3	203.47	17.15	1.14
Osteoblast - differentiated, donor3	11425-118G3	179.39	33.52	1.24
Osteoblast, donor1	11277-116H8	246.84	44.36	4.89
Osteoblast, donor2	11354-117H4	164.34	47.06	4.21
Osteoblast, donor3	11426-118G4	137.74	27.37	0.71
Pancreatic stromal cells, donor1	11249-116E7	221.79	66.12	0.51
Pericytes, donor1	11491-119E6	216.86	25.93	1.56
Pericytes, donor2	11571-120E5	186.30	20.15	0.91
Pericytes, donor3	11652-122E5	173.95	48.22	1.02
Perineurial Cells, donor1	11499-119F5	171.00	69.28	1.02
Perineurial Cells, donor2	11579-120F4	157.89	51.80	0.74
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	57.69	13.07	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	32.08	9.79	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	37.66	9.32	0.52
Placental Epithelial Cells, donor1	11278-116H9	148.04	64.81	1.20
Placental Epithelial Cells, donor2	11355-117H5	177.42	55.44	1.11
Placental Epithelial Cells, donor3	11427-118G5	155.88	39.27	1.96
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	157.59	63.61	0.95
Preadipocyte - breast, donor1	11467-119B9	215.91	60.97	1.31
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	95.29	34.33	0.91
Preadipocyte - breast, donor2	11328-117E5	169.76	51.78	1.80
Preadipocyte - omental, donor1	11468-119C1	226.76	73.95	1.28
Preadipocyte - omental, donor2	11329-117E6	189.43	61.11	0.00
Preadipocyte - omental, donor3	11403-118D8	165.74	59.30	0.86
Preadipocyte - perirenal, donor1	11469-119C2	182.09	38.39	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	115.78	25.18	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	147.51	44.45	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	190.21	57.56	0.85
Preadipocyte - visceral, donor1	11280-116I2	186.11	63.53	0.84
Preadipocyte - visceral, donor2	11357-117H7	142.66	35.43	0.00
Preadipocyte - visceral, donor3	11429-118G7	136.99	35.11	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	138.18	70.75	3.02
Prostate Epithelial Cells, donor2	11331-117E8	105.76	41.44	0.68
Prostate Epithelial Cells, donor3	11404-118D9	87.20	36.19	0.24
Prostate Stromal Cells, donor1	11254-116F3	184.86	61.51	0.34
Prostate Stromal Cells, donor2	11332-117E9	221.61	59.17	0.90
Prostate Stromal Cells, donor3	11405-118E1	232.22	49.11	1.36
Renal Cortical Epithelial Cells, donor1	11516-119H4	181.03	61.68	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	133.63	75.62	0.49
Renal Epithelial Cells, donor1	11517-119H5	116.66	21.30	1.01
Renal Epithelial Cells, donor2	11597-120H4	212.68	51.22	2.85
Renal Epithelial Cells, donor3	11678-122H4	207.18	75.48	2.65
Renal Glomerular Endothelial Cells, donor1	11514-119H2	118.47	21.11	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	132.47	28.97	1.08
Renal Glomerular Endothelial Cells, donor3	11675-122H1	80.81	25.09	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	104.47	9.32	0.00
Renal Mesangial Cells, donor1	11518-119H6	201.82	51.50	0.22
Renal Mesangial Cells, donor2	11598-120H5	117.87	62.70	0.00
Renal Mesangial Cells, donor3	11679-122H5	143.98	23.58	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	161.32	87.24	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	105.42	53.55	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	135.76	48.98	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	130.16	61.19	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	147.24	35.53	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	112.17	28.82	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	225.31	44.41	2.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	98.22	43.30	1.47
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	122.40	45.56	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	150.80	100.72	2.75
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	89.91	37.12	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	87.12	30.95	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	80.44	32.77	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	144.67	57.33	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	136.70	52.97	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	111.07	43.82	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	107.71	45.07	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	74.89	25.05	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	87.89	32.98	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	117.19	52.32	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	102.14	32.71	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	94.65	37.02	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	112.63	39.39	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	68.06	15.49	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	69.87	26.64	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	138.11	43.78	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	63.70	14.47	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	86.83	31.44	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	106.75	39.91	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	85.01	24.35	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	80.17	27.47	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	86.99	30.42	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	65.46	19.51	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	84.25	28.45	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	111.62	42.31	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	120.77	33.26	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	94.44	41.47	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	103.36	32.97	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	97.87	33.80	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	89.15	31.85	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	82.93	27.57	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	103.90	26.24	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	52.96	19.24	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	85.41	31.23	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	109.01	31.12	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	57.34	17.28	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	80.94	39.24	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	83.85	18.41	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	109.64	39.95	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	80.50	29.05	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	118.77	29.45	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	120.72	43.81	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	92.31	29.22	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	139.66	39.36	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	155.47	42.62	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	114.54	39.59	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	149.43	46.51	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	161.85	62.15	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	164.28	68.14	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	143.77	43.70	2.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	153.36	58.36	2.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	150.97	62.00	2.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	189.27	76.98	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	176.31	66.59	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	126.21	63.10	0.00
Schwann Cells, donor1	11498-119F4	201.24	35.73	1.32
Schwann Cells, donor2	11578-120F3	176.93	44.23	0.00
Schwann Cells, donor3	11659-122F3	129.26	56.74	5.04
Sebocyte, donor1	11220-116B5	146.80	69.02	0.55
Sebocyte, donor2	11301-117B5	87.32	39.98	0.00
Sebocyte, donor3	11378-118B1	152.32	42.05	0.41
Sertoli Cells, donor1	11255-116F4	225.30	82.83	0.00
Sertoli Cells, donor2	11333-117F1	194.88	48.01	0.00
Skeletal Muscle Cells, donor1	11281-116I3	198.30	34.14	1.94
Skeletal Muscle Cells, donor2	11358-117H8	91.08	10.12	0.00
Skeletal Muscle Cells, donor3	11430-118G8	97.82	10.87	0.00
Skeletal Muscle Cells, donor4	11451-119A2	124.89	35.50	0.47
Skeletal Muscle Cells, donor5	11455-119A6	133.33	37.31	0.45
Skeletal Muscle Cells, donor6	11459-119B1	135.90	44.32	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	247.98	90.22	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	169.80	53.37	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	138.10	46.43	0.99
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	157.47	31.51	0.76
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	85.40	15.92	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	130.99	17.48	0.28
Skin - palm, donor1	10286-104F7	75.21	8.06	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	81.74	35.89	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	93.24	38.44	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	83.22	41.41	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	175.43	110.51	1.25
Small Airway Epithelial Cells, donor2	11334-117F2	79.75	38.54	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	73.79	37.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	75.85	33.50	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	238.23	33.64	2.16
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	246.12	59.81	1.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	166.36	49.38	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	78.23	26.96	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	141.37	31.11	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	180.78	44.81	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	151.11	35.03	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	131.21	34.60	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	174.89	46.77	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	136.48	31.88	0.90
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	178.10	57.63	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	151.80	50.21	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	132.11	28.33	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	230.51	42.13	0.81
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	108.99	16.13	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	130.07	35.11	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	73.45	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	80.11	13.83	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	184.49	54.57	1.03
Smooth Muscle Cells - Colonic, donor2	11320-117D6	131.94	42.83	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	143.58	47.13	0.84
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	132.25	27.22	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	103.48	26.95	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	92.35	28.69	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	146.12	54.62	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	163.81	75.15	1.26
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	190.41	28.18	1.01
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	139.94	42.10	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	128.61	33.81	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	129.81	51.93	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	205.73	76.43	1.07
Smooth Muscle Cells - Prostate, donor2	11335-117F3	146.01	37.44	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	186.95	39.32	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	191.18	45.84	2.56
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	116.28	34.51	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	46.52	7.75	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	116.73	26.04	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	140.36	27.77	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	109.69	16.92	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	183.49	43.95	1.77
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	103.13	45.24	0.83
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	132.67	34.57	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	115.42	31.81	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	98.92	25.24	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	106.99	29.33	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	173.28	76.16	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	224.05	79.01	0.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	119.05	16.19	1.43
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	106.43	26.67	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	224.93	83.52	1.55
Smooth Muscle Cells - Uterine, donor3	11466-119B8	105.04	42.42	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	125.75	27.21	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	121.65	28.30	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	152.87	68.07	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	202.67	40.61	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	146.78	24.98	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	129.19	53.96	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	140.69	30.47	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	140.16	24.76	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	161.35	35.53	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	182.43	42.17	0.46
Synoviocyte, donor1	11291-117A4	187.51	64.97	0.34
Synoviocyte, donor2	11368-117I9	183.05	48.28	0.67
Synoviocyte, donor3	11440-118H9	167.56	38.20	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	127.21	50.38	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	114.96	9.91	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	94.70	14.36	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	141.50	65.81	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	103.60	34.40	1.93
Tracheal Epithelial Cells, donor3	11441-118I1	92.20	30.35	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	106.66	41.83	0.98
Urethra, donor2	10319-105A4	70.14	10.79	1.80
Urothelial Cells, donor1	11520-119H8	178.79	82.62	0.27
Urothelial Cells, donor2	11600-120H7	108.55	44.86	0.00
Urothelial Cells, donor3	11681-122H7	93.52	41.26	0.00
Urothelial cells, donor0	11216-116B1	155.80	123.93	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	57.84	24.91	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	71.48	18.58	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	30.12	10.27	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	51.31	18.59	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	47.06	15.69	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	57.27	19.78	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	67.92	27.53	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	41.99	14.61	0.00
Wilms' tumor cell line:G-401	10809-111A8	167.77	40.59	1.48
Wilms' tumor cell line:HFWT	10597-108E3	66.00	14.96	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	175.41	70.67	1.40
achilles tendon, donor2	10292-104G4	59.93	24.80	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	25.24	23.20	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	73.37	71.51	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	75.50	62.92	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	63.13	48.71	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	156.84	68.02	3.09
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	118.85	74.02	1.27
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	82.75	40.83	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	267.03	70.94	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	122.10	84.53	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	66.40	31.84	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	60.90	39.38	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	101.41	31.20	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	96.21	64.14	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	92.69	42.46	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	121.57	37.41	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	67.85	19.06	1.86
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	178.89	64.57	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	7.37	3.07	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	42.67	16.64	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	44.58	17.59	1.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	50.31	18.53	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	81.08	40.32	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	75.38	32.02	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	65.04	48.31	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	217.71	84.37	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	92.02	28.35	3.93
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	168.70	63.73	0.00
adenocarcinoma cell line:IM95m	10796-110I4	115.39	65.00	0.00
adipose tissue, adult, pool1	10010-101C1	97.57	27.15	1.40
adipose, donor1	10184-103D4	137.81	180.61	4.69
adipose, donor2	10185-103D5	69.34	38.93	5.27
adipose, donor3	10186-103D6	77.06	54.73	4.08
adipose, donor4	10187-103D7	91.01	44.20	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	138.25	20.99	0.63
adrenal gland, adult, pool1	10081-102A9	76.39	25.46	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	111.66	124.33	0.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	102.19	21.44	0.00
amniotic membrane cells, donor1	12235-129G3	143.51	67.70	1.62
amniotic membrane cells, donor2	12236-129G4	238.70	93.99	0.68
amniotic membrane cells, donor3	12237-129G5	155.25	70.70	2.06
amygdala - adult, donor10196	10167-103B5	59.29	16.60	1.19
amygdala, adult, donor10252	10151-102I7	65.49	21.29	3.04
amygdala, newborn, donor10223	10360-105E9	28.73	12.59	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	210.35	92.70	1.53
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	102.37	44.79	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	116.91	20.04	0.00
aorta, adult, pool1	10052-101G7	95.71	21.77	1.18
appendix, adult	10189-103D9	62.10	22.12	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	88.05	33.36	0.34
artery, adult	10190-103E1	135.87	46.20	4.08
astrocytoma cell line:TM-31	10425-106D2	246.56	139.36	3.33
b cell line:RPMI1788	10427-106D4	67.81	34.94	1.34
basal cell carcinoma cell line:TE 354.T	10702-109G9	149.54	52.71	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	169.88	92.38	1.69
bile duct carcinoma cell line:TFK-1	10496-107C1	68.63	16.57	1.34
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	101.78	20.69	2.80
bladder, adult, pool1	10011-101C2	104.95	25.42	2.61
blood, adult, pool1	10053-101G8	33.22	6.64	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	111.33	58.23	0.86
bone marrow, adult	10192-103E3	128.89	41.16	1.35
brain, adult, donor1	10084-102B3	63.55	26.65	1.03
brain, adult, pool1	10012-101C3	83.30	31.40	2.56
brain, fetal, pool1	10085-102B4	85.48	26.71	0.00
breast carcinoma cell line:MCF7	10482-107A5	109.02	23.79	2.64
breast carcinoma cell line:MDA-MB-453	10419-106C5	106.35	73.40	1.00
breast, adult, donor1	10080-102A8	77.66	22.10	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	46.75	22.10	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	67.72	23.81	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	124.55	44.66	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	76.74	27.60	0.24
carcinoid cell line:NCI-H1770	10703-109H1	77.58	49.37	0.00
carcinoid cell line:NCI-H727	10735-110B6	75.25	39.71	0.98
carcinoid cell line:SK-PN-DW	10719-109I8	62.43	34.86	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	141.07	40.99	2.40
caudate nucleus - adult, donor10196	10177-103C6	70.23	19.57	2.30
caudate nucleus, adult, donor10252	10164-103B2	64.76	20.58	2.18
caudate nucleus, adult, donor10258	10379-105H1	91.70	26.74	1.53
caudate nucleus, newborn, donor10223	10354-105E3	31.13	9.16	0.00
cerebellum - adult, donor10196	10173-103C2	61.18	11.65	0.00
cerebellum, adult, donor10252	10166-103B4	67.04	20.71	4.91
cerebellum, adult, pool1	10083-102B2	74.51	30.36	4.48
cerebellum, newborn, donor10223	10357-105E6	83.03	21.59	6.64
cerebral meninges, adult	10188-103D8	83.46	30.00	2.77
cerebrospinal fluid, donor2	10294-104G6	67.24	18.27	0.73
cervical cancer cell line:D98-AH2	10552-107I3	632.64	274.91	35.66
cervical cancer cell line:ME-180	10553-107I4	108.05	67.94	1.99
cervix, adult, pool1	10013-101C4	122.00	38.74	2.62
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	252.20	68.28	3.76
chondrosarcoma cell line:SW 1353	10700-109G7	67.93	18.29	0.00
choriocarcinoma cell line:BeWo	10423-106C9	203.69	48.59	4.97
choriocarcinoma cell line:SCH	10785-110H2	149.83	17.50	4.07
choriocarcinoma cell line:T3M-3	10618-108G6	64.51	14.71	3.79
chorionic membrane cells, donor1	12238-129G6	148.73	53.00	2.28
chorionic membrane cells, donor2	12239-129G7	183.45	79.25	0.50
chorionic membrane cells, donor3	12240-129G8	140.12	65.94	2.75
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	44.43	39.38	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	80.87	32.46	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	281.09	99.68	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	154.85	67.28	1.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	189.15	81.51	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	149.86	71.47	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	407.53	182.86	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	520.21	143.34	2.35
clear cell carcinoma cell line:JHOC-5	10638-108I8	278.41	89.15	2.06
clear cell carcinoma cell line:TEN	10636-108I6	72.87	39.04	0.52
colon carcinoma cell line:CACO-2	10513-107D9	197.14	89.32	1.83
colon carcinoma cell line:COLO-320	10420-106C6	178.64	72.98	0.38
colon, adult, donor1	10082-102B1	63.07	39.27	0.00
colon, adult, pool1	10014-101C5	134.31	59.57	0.71
colon, fetal, donor1	10070-101I7	80.34	25.34	0.62
common myeloid progenitor CMP, donor1	12130-128D6	50.42	9.17	0.00
common myeloid progenitor CMP, donor2	12134-128E1	325.48	250.37	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	74.36	45.04	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	85.58	57.20	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	89.82	68.53	0.28
corpus callosum, adult, pool1	10042-101F6	126.04	31.51	5.20
cruciate ligament, donor2	10295-104G7	67.27	20.26	0.00
diaphragm, fetal, donor1	10069-101I6	86.68	24.08	1.61
diencephalon, adult	10193-103E4	69.60	18.24	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	58.09	36.28	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	148.73	74.11	1.80
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	212.80	37.55	0.72
ductus deferens, adult	10196-103E7	101.66	38.87	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	95.06	28.80	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	124.32	43.40	2.21
dura mater, adult, donor1	10041-101F5	119.34	28.41	2.81
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	150.34	74.17	5.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	173.24	74.37	1.43
embryonic pancreas cell line:1B2C6	10604-108F1	215.82	67.21	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	131.07	27.24	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	96.33	25.32	0.31
embryonic pancreas cell line:2C6	10603-108E9	64.36	14.45	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	215.20	61.34	2.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	203.35	44.04	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	150.52	44.71	0.48
epidermoid carcinoma cell line:A431	10426-106D3	125.16	64.03	1.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	280.13	122.19	1.54
epididymis, adult	10197-103E8	128.31	34.33	1.88
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	290.78	75.75	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	287.46	71.57	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	160.54	121.75	3.54
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	156.59	96.45	3.35
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	175.44	116.06	3.58
esophagus, adult, pool1	10015-101C6	93.54	40.03	0.96
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	171.07	17.78	3.26
eye - muscle inferior rectus, donor1	10272-104E2	41.05	9.66	2.41
eye - muscle lateral, donor2	10298-104H1	71.54	23.15	4.21
eye - muscle medial, donor2	10299-104H2	41.67	4.46	0.00
eye - muscle superior, donor2	10297-104G9	79.11	11.46	1.15
eye - vitreous humor, donor1	10268-104D7	48.09	18.95	1.46
eye, fetal, donor1	10054-101G9	105.51	29.24	2.80
fibrosarcoma cell line:HT-1080	10758-110E2	126.43	65.78	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	164.06	51.05	1.66
frontal lobe, adult, pool1	10040-101F4	89.79	36.40	2.06
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	133.61	31.23	2.70
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	403.33	121.70	1.83
gall bladder, adult	10198-103E9	104.78	37.18	2.41
gamma delta positive T cells, donor1	11937-126A2	39.19	13.42	0.00
gamma delta positive T cells, donor2	11938-126A3	20.54	9.34	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	103.07	33.79	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	129.78	27.47	1.74
gastric cancer cell line:AZ521	10549-107H9	153.30	44.27	0.82
gastric cancer cell line:GSS	10560-108A2	155.59	29.29	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	144.16	44.55	3.20
giant cell carcinoma cell line:LU65	10487-107B1	132.98	64.14	2.18
giant cell carcinoma cell line:Lu99B	10433-106E1	311.41	62.98	3.78
glassy cell carcinoma cell line:HOKUG	10688-109F4	89.54	42.65	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	167.51	64.60	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	148.02	56.32	1.12
glioblastoma cell line:T98G	10485-107A8	288.96	137.75	1.32
glioma cell line:GI-1	10413-106B8	165.48	50.37	0.59
globus pallidus - adult, donor10196	10175-103C4	88.93	21.14	0.00
globus pallidus, adult, donor10252	10161-103A8	102.03	27.09	5.13
globus pallidus, adult, donor10258	10367-105F7	67.09	21.91	2.74
globus pallidus, newborn, donor10223	10364-105F4	52.76	11.72	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	53.84	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	207.64	32.79	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	324.05	104.53	0.00
granulosa cell tumor cell line:KGN	10624-108H3	137.92	34.88	0.64
hIPS +CCl2, biol_rep1	14383-156B9	130.85	44.53	4.13
hIPS +CCl2, biol_rep2	14384-156C1	127.12	51.67	5.03
hIPS +CCl2, biol_rep3	14385-156C2	144.92	38.65	4.51
hIPS, biol_rep1	14380-156B6	143.73	45.99	1.44
hIPS, biol_rep2	14381-156B7	115.91	40.47	4.12
hIPS, biol_rep3	14382-156B8	111.45	30.90	4.41
hairy cell leukemia cell line:Mo	10712-109I1	81.32	31.32	0.00
heart - mitral valve, adult	10205-103F7	80.42	24.52	0.30
heart - pulmonic valve, adult	10206-103F8	105.11	38.70	1.31
heart - tricuspid valve, adult	10207-103F9	41.63	9.99	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	118.96	45.91	2.04
heart, adult, diseased, donor1	10051-101G6	110.29	41.73	0.85
heart, adult, pool1	10016-101C7	120.97	34.96	1.15
heart, fetal, pool1	10046-101G1	153.51	85.84	1.23
hepatic mesenchymal tumor cell line:LI90	10778-110G4	106.13	49.98	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	64.22	11.89	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	165.52	59.34	1.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	164.10	64.09	2.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	171.29	67.81	2.32
hepatoma cell line:Li-7	10484-107A7	197.30	95.31	1.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	82.41	38.59	1.71
hippocampus - adult, donor10196	10169-103B7	54.89	15.14	0.00
hippocampus, adult, donor10252	10153-102I9	94.09	27.55	1.84
hippocampus, adult, donor10258	10374-105G5	91.12	24.90	2.49
hippocampus, newborn, donor10223	10363-105F3	29.26	7.05	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	123.29	190.43	9.16
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	74.61	91.70	3.14
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	86.07	115.78	7.62
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	76.12	128.56	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	77.98	115.16	2.84
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	111.98	186.39	3.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	91.97	77.66	3.21
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	95.65	83.59	3.23
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	88.00	62.56	5.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	170.96	143.97	5.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	118.77	96.27	4.82
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	169.67	154.86	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	100.62	71.51	4.85
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	92.85	77.62	5.90
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	131.79	158.84	6.11
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	113.40	106.53	4.01
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	102.48	87.65	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	109.95	108.45	3.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	73.28	57.65	4.33
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	86.85	48.20	5.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	93.97	59.20	4.07
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	116.43	69.89	5.88
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	115.25	72.58	4.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	105.22	61.28	4.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	142.07	72.24	3.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	130.95	69.04	3.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	199.26	115.14	5.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	134.14	60.56	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	127.33	61.13	3.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	150.40	73.54	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	108.60	45.51	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	115.56	56.45	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	101.84	49.51	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	149.30	55.22	2.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	147.66	61.34	3.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	135.10	68.56	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	132.35	68.83	5.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	163.56	110.52	4.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	154.15	70.24	2.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	120.11	78.85	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	413.16	543.29	13.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	187.98	154.55	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	129.71	62.39	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	121.96	61.52	2.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	128.47	56.58	3.20
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	151.56	70.41	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	190.68	86.13	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	147.90	72.20	0.81
immature langerhans cells, donor1	11904-125F5	376.05	80.39	3.63
immature langerhans cells, donor2	11905-125F6	437.26	80.80	3.17
insula, adult, pool1	10039-101F3	88.01	32.55	1.80
keratoacanthoma cell line:HKA-1	10791-110H8	72.18	71.86	0.00
kidney, adult, pool1	10017-101C8	147.49	59.88	2.50
kidney, fetal, pool1	10045-101F9	143.52	48.52	2.48
large cell lung carcinoma cell line:IA-LM	10509-107D5	338.29	87.34	2.13
large cell lung carcinoma cell line:NCI-H460	10839-111E2	81.15	34.42	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	169.55	76.15	1.83
left atrium, adult, donor1	10079-102A7	95.89	33.78	0.00
left ventricle, adult, donor1	10078-102A6	107.20	34.38	3.54
leiomyoblastoma cell line:G-402	10721-110A1	76.06	13.68	0.00
leiomyoma cell line:10964C	10569-108B2	227.05	49.22	1.08
leiomyoma cell line:15242A	10570-108B3	169.57	53.80	1.09
leiomyoma cell line:15425	10571-108B4	185.75	44.68	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	228.58	101.59	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	127.56	38.69	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	223.37	52.77	1.30
liposarcoma cell line:KMLS-1	10782-110G8	136.68	37.02	1.25
liposarcoma cell line:SW 872	10726-110A6	145.84	54.22	0.73
liver, adult, pool1	10018-101C9	121.22	48.78	0.32
liver, fetal, pool1	10086-102B5	88.43	22.58	1.88
locus coeruleus - adult, donor10196	10182-103D2	62.56	15.60	0.58
locus coeruleus, adult, donor10252	10165-103B3	80.46	26.76	2.40
locus coeruleus, adult, donor10258	10375-105G6	89.44	25.39	2.26
locus coeruleus, newborn, donor10223	10362-105F2	58.05	25.24	0.84
lung adenocarcinoma cell line:A549	10499-107C4	131.48	42.07	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	99.96	64.80	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	102.29	35.99	0.40
lung, adult, pool1	10019-101D1	91.90	31.07	0.35
lung, fetal, donor1	10068-101I5	185.23	52.51	1.71
lung, right lower lobe, adult, donor1	10075-102A3	85.23	23.83	2.29
lymph node, adult, donor1	10077-102A5	56.33	12.78	0.00
lymphangiectasia cell line:DS-1	10727-110A7	113.31	53.04	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	48.45	31.09	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	97.69	23.79	0.85
mature adipocyte, donor1	12231-129F8	217.55	63.05	0.89
mature adipocyte, donor2	12232-129F9	229.11	59.56	1.04
mature adipocyte, donor3	12233-129G1	291.11	99.80	0.71
mature adipocyte, donor4	12234-129G2	242.69	83.44	1.32
maxillary sinus tumor cell line:HSQ-89	10414-106B9	126.75	35.50	5.48
medial frontal gyrus - adult, donor10196	10170-103B8	67.68	27.07	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	73.38	19.49	2.94
medial frontal gyrus, adult, donor10258	10368-105F8	73.07	24.14	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	35.40	25.59	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	71.89	25.48	1.18
medial temporal gyrus, adult, donor10252	10156-103A3	70.25	20.37	1.70
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	94.39	13.48	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	57.41	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	25.84	14.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	107.73	20.12	0.65
medulla oblongata, adult, donor10252	10155-103A2	111.30	28.79	1.86
medulla oblongata, adult, pool1	10038-101F2	102.12	27.59	2.94
medulla oblongata, newborn, donor10223	10361-105F1	65.96	20.48	1.04
medulloblastoma cell line:D283 Med	10838-111E1	199.71	32.99	5.98
medulloblastoma cell line:ONS-76	10759-110E3	82.17	39.62	0.61
melanoma cell line:COLO 679	10514-107E1	120.03	50.89	0.57
melanoma cell line:G-361	10465-106H6	118.36	33.66	1.09
meningioma cell line:HKBMM	10691-109F7	118.31	59.16	1.09
merkel cell carcinoma cell line:MKL-1	10843-111E6	81.07	60.80	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	57.81	25.66	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	168.32	50.63	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	180.51	46.17	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	158.60	39.34	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	173.21	47.06	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	167.73	34.47	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	167.27	39.56	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	296.07	89.59	1.72
mesenchymal precursor cell - cardiac, donor2	11753-123G7	198.52	51.53	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	153.73	45.89	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	185.14	59.01	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	183.23	57.47	1.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	143.93	38.53	1.98
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	170.47	46.35	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	163.37	46.43	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	226.42	73.70	1.43
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	143.06	47.45	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	216.42	58.35	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	201.77	49.25	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	282.78	87.69	4.20
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	164.53	43.04	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	179.53	54.27	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	199.91	64.43	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	141.93	55.80	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	205.88	89.68	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	161.20	32.88	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	169.84	39.39	1.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	175.12	40.31	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	156.20	40.98	1.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	164.75	50.84	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	164.83	46.37	1.69
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	171.34	41.26	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	165.89	44.49	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	386.43	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	186.32	51.34	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	173.57	42.61	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	172.81	38.46	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	163.53	34.47	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	159.44	40.95	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	169.89	46.67	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	179.13	49.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	229.69	49.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	144.62	41.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	188.05	47.74	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	209.52	39.28	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	194.57	52.77	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	179.09	44.98	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	160.93	42.37	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	176.29	33.58	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	178.82	41.73	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	190.69	61.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	169.59	37.36	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	222.98	51.18	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	297.58	27.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	196.35	51.94	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	176.59	43.11	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	184.83	32.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	199.59	35.93	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	175.64	51.66	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	156.88	50.12	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	155.71	57.99	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	164.48	41.27	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	162.09	39.27	1.87
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	171.09	45.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	150.20	39.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	159.22	38.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	172.10	38.55	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	187.53	48.49	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	144.67	34.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	169.19	41.98	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	265.57	69.72	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	250.77	74.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	223.00	68.42	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	188.14	40.66	1.82
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	257.58	94.90	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	206.74	48.60	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	189.89	58.54	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	148.62	40.56	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	187.43	36.67	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	44.88	13.93	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	563.44	149.07	1.18
mesothelioma cell line:ACC-MESO-4	10494-107B8	175.61	42.40	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	401.72	102.57	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	563.17	265.71	1.23
mesothelioma cell line:Mero-25	10850-111F4	303.89	142.53	3.86
mesothelioma cell line:Mero-41	10851-111F5	307.55	142.28	0.73
mesothelioma cell line:Mero-48a	10852-111F6	342.77	86.14	1.55
mesothelioma cell line:Mero-82	10853-111F7	207.09	68.86	0.26
mesothelioma cell line:Mero-83	10854-111F8	253.63	73.19	1.02
mesothelioma cell line:Mero-84	10855-111F9	194.89	70.78	0.51
mesothelioma cell line:Mero-95	10856-111G1	295.86	95.24	2.48
mesothelioma cell line:NCI-H2052	10847-111F1	135.33	68.41	0.17
mesothelioma cell line:NCI-H226	10846-111E9	327.23	133.57	1.45
mesothelioma cell line:NCI-H2452	10848-111F2	286.98	114.28	0.34
mesothelioma cell line:NCI-H28	10845-111E8	234.87	66.42	5.34
mesothelioma cell line:No36	10857-111G2	292.60	112.54	0.98
mesothelioma cell line:ONE58	10858-111G3	276.37	98.36	0.81
migratory langerhans cells, donor1	11901-125F2	379.24	112.85	0.38
migratory langerhans cells, donor2	11902-125F3	317.01	77.91	0.37
migratory langerhans cells, donor3	11903-125F4	342.99	122.41	0.90
mixed mullerian tumor cell line:HTMMT	10689-109F5	252.37	94.03	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	224.86	83.71	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	141.90	50.22	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	50.43	38.63	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	263.88	121.59	3.33
myeloma cell line:PCM6	10474-106I6	100.02	92.31	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	140.52	39.06	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	103.56	30.01	1.18
nasal epithelial cells, donor1, tech_rep1	12226-129F3	129.92	59.72	0.89
nasal epithelial cells, donor1, tech_rep2	12226-129F3	134.65	74.72	0.59
nasal epithelial cells, donor2	12227-129F4	92.18	55.20	1.66
neuroblastoma cell line:CHP-134	10508-107D4	126.99	36.81	2.30
neuroblastoma cell line:NB-1	10539-107G8	253.69	74.27	5.24
neuroblastoma cell line:NBsusSR	10607-108F4	109.24	50.19	1.48
neuroblastoma cell line:NH-12	10555-107I6	190.26	46.77	4.47
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	126.20	28.70	3.08
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	104.85	32.94	1.43
neuroectodermal tumor cell line:TASK1	10774-110F9	112.71	30.59	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	32.42	6.36	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	103.54	28.75	0.53
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	26.56	0.00
neutrophil PMN, donor3	12141-128E8	28.41	28.41	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	82.02	60.55	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	259.36	82.45	4.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	185.63	44.56	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	202.85	58.86	0.53
nucleus accumbens, adult, pool1	10037-101F1	85.58	28.31	2.72
occipital cortex - adult, donor10196	10172-103C1	63.87	12.36	0.00
occipital cortex, adult, donor10252	10163-103B1	78.90	20.13	1.88
occipital cortex, newborn, donor10223	10355-105E4	40.03	17.47	1.09
occipital lobe, adult, donor1	10076-102A4	82.66	25.72	2.36
occipital lobe, fetal, donor1	10073-102A1	51.49	12.44	0.43
occipital pole, adult, pool1	10036-101E9	83.41	33.35	2.76
olfactory region, adult	10195-103E6	68.01	24.45	2.48
optic nerve, donor1	10277-104E7	22.01	8.00	6.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	184.08	57.64	2.16
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	334.81	192.62	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	148.50	67.56	2.20
oral squamous cell carcinoma cell line:SAS	10544-107H4	94.02	28.30	1.50
osteoclastoma cell line:Hs 706.T	10704-109H2	105.24	38.22	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	89.70	46.72	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	124.27	37.75	1.06
ovary, adult, pool1	10020-101D2	108.14	29.26	3.93
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	106.14	50.23	0.18
pancreas, adult, donor1	10049-101G4	110.05	48.91	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	73.24	10.34	5.03
papillary adenocarcinoma cell line:8505C	10437-106E5	205.45	101.36	3.75
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	185.45	91.07	0.83
paracentral gyrus, adult, pool1	10035-101E8	93.26	38.99	2.11
parietal cortex, adult, donor10258	10373-105G4	56.52	32.30	1.47
parietal lobe - adult, donor10196	10171-103B9	71.48	25.39	1.88
parietal lobe, adult, donor10252	10157-103A4	60.14	18.53	2.57
parietal lobe, adult, pool1	10034-101E7	80.98	35.60	2.20
parietal lobe, fetal, donor1	10072-101I9	58.19	24.25	2.91
parietal lobe, newborn, donor10223	10356-105E5	31.40	13.09	0.75
parotid gland, adult	10199-103F1	147.38	48.10	3.70
penis, adult	10200-103F2	89.16	38.13	3.22
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	77.54	17.29	1.49
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	133.89	67.17	1.17
pineal gland - adult, donor10196	10179-103C8	125.14	30.96	1.29
pineal gland, adult, donor10252	10160-103A7	181.22	64.55	5.33
pineal gland, adult, donor10258	10377-105G8	178.72	45.15	1.88
pituitary gland - adult, donor10196	10180-103C9	102.19	36.42	2.02
pituitary gland, adult, donor10252	10162-103A9	113.10	41.17	2.61
pituitary gland, adult, donor10258	10378-105G9	122.58	26.39	1.70
placenta, adult, pool1	10021-101D3	111.59	34.72	1.72
plasma cell leukemia cell line:ARH-77	10840-111E3	30.59	19.33	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	173.54	73.15	1.09
pons, adult, pool1	10033-101E6	86.58	27.89	3.44
postcentral gyrus, adult, pool1	10032-101E5	87.87	36.53	2.53
promyelocytes/myelocytes PMC, donor1	12132-128D8	27.19	6.27	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	165.24	104.65	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	328.60	93.89	0.00
prostate cancer cell line:DU145	10490-107B4	307.64	121.34	1.02
prostate cancer cell line:PC-3	10439-106E7	163.53	75.69	0.36
prostate, adult, pool1	10022-101D4	139.94	36.82	2.18
putamen, adult, donor10196	10176-103C5	44.62	13.93	0.94
putamen, adult, donor10252	10152-102I8	94.11	39.21	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	87.42	31.69	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	64.75	20.30	2.42
putamen, newborn, donor10223	10365-105F5	24.74	20.99	0.00
rectal cancer cell line:TT1TKB	10469-106I1	101.54	30.55	2.04
rectum, fetal, donor1	10067-101I4	115.45	30.60	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	118.08	71.87	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	166.10	89.88	0.41
retina, adult, pool1	10030-101E3	152.08	40.36	3.68
retinoblastoma cell line:Y79	10475-106I7	644.57	154.32	9.35
rhabdomyosarcoma cell line:KYM-1	10787-110H4	75.86	18.32	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	196.84	46.96	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	79.57	17.43	0.00
salivary acinar cells, donor1	11771-123I7	115.73	37.07	0.32
salivary acinar cells, donor2	11772-123I8	141.82	48.05	0.41
salivary acinar cells, donor3	11773-123I9	46.34	21.19	0.00
salivary gland, adult, pool1	10093-102C3	209.91	66.92	3.43
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	195.01	49.74	1.01
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	181.62	50.43	0.71
seminal vesicle, adult	10201-103F3	123.27	34.92	2.65
serous adenocarcinoma cell line:JHOS-2	10639-108I9	109.07	26.48	2.43
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	116.51	42.02	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	127.45	49.17	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	153.13	31.03	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	127.55	67.86	2.32
signet ring carcinoma cell line:NUGC-4	10483-107A6	66.58	32.90	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	58.87	7.80	2.13
skeletal muscle, adult, pool1	10023-101D5	138.41	25.07	5.16
skeletal muscle, fetal, donor1	10066-101I3	78.39	17.09	2.01
skin, adult, donor1	10074-102A2	67.85	27.14	0.00
skin, fetal, donor1	10065-101I2	92.16	34.09	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	117.40	73.04	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	162.96	38.46	5.36
small cell lung carcinoma cell line:DMS 144	10841-111E4	356.00	46.07	1.16
small cell lung carcinoma cell line:LK-2	10541-107H1	111.09	54.23	2.47
small cell lung carcinoma cell line:NCI-H82	10842-111E5	158.12	49.54	1.29
small cell lung carcinoma cell line:WA-hT	10562-108A4	103.95	69.73	1.74
small intestine, adult, pool1	10024-101D6	139.87	78.59	0.84
small intestine, fetal, donor1	10064-101I1	98.52	36.85	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	106.68	76.94	1.54
smooth muscle, adult, pool1	10048-101G3	80.90	18.61	4.91
somatostatinoma cell line:QGP-1	10781-110G7	49.85	17.69	0.27
spinal cord - adult, donor10196	10181-103D1	69.05	16.06	1.38
spinal cord, adult, donor10252	10159-103A6	106.45	34.70	1.58
spinal cord, adult, donor10258	10369-105F9	130.75	38.74	3.46
spinal cord, fetal, donor1	10056-101H2	114.65	29.88	3.05
spinal cord, newborn, donor10223	10359-105E8	58.78	26.18	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	86.48	31.07	0.15
spleen, adult, pool1	10025-101D7	71.26	24.56	0.44
spleen, fetal, pool1	10044-101F8	79.61	23.20	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	101.96	48.96	1.97
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	63.99	44.43	0.95
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	178.57	53.47	1.75
squamous cell carcinoma cell line:T3M-5	10616-108G4	80.92	26.97	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	177.28	82.17	5.40
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	143.60	63.54	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	202.23	90.11	0.42
stomach, fetal, donor1	10062-101H8	69.42	22.43	0.00
submaxillary gland, adult	10202-103F4	103.11	31.33	2.85
substantia nigra - adult, donor10196	10178-103C7	162.82	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	111.95	32.19	3.32
substantia nigra, adult, donor10258	10371-105G2	129.31	29.48	2.59
substantia nigra, newborn, donor10223	10358-105E7	55.82	14.13	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	183.64	62.13	1.15
temporal lobe, adult, pool1	10031-101E4	82.14	26.70	1.86
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	61.97	15.67	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	73.40	17.14	3.08
tenocyte, donor1	11763-123H8	168.62	48.18	0.35
tenocyte, donor2	11765-123I1	162.14	33.95	0.00
tenocyte, donor3	11768-123I4	163.83	44.11	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	245.76	77.50	9.52
teratocarcinoma cell line:NCR-G1	10798-110I6	113.92	30.68	2.16
teratocarcinoma cell line:PA-1	10807-111A6	127.24	71.29	4.96
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	201.59	46.84	8.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	65.80	13.99	3.03
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	136.00	22.36	2.73
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	120.51	18.89	18.57
testis, adult, pool1	10026-101D8	113.60	22.33	2.68
testis, adult, pool2	10096-102C6	118.18	16.69	6.32
thalamus - adult, donor10196	10168-103B6	88.32	23.18	5.52
thalamus, adult, donor10252	10154-103A1	90.33	27.82	2.66
thalamus, adult, donor10258, tech_rep1	10370-105G1	180.14	38.49	7.70
thalamus, adult, donor10258, tech_rep2	10370-105G1	68.84	22.23	3.29
thalamus, newborn, donor10223	10366-105F6	26.46	8.63	1.15
throat, adult	10209-103G2	101.37	31.21	1.25
throat, fetal, donor1	10061-101H7	76.18	28.03	2.74
thymic carcinoma cell line:Ty-82	10803-111A2	126.39	44.52	0.20
thymus, adult, pool1	10027-101D9	52.89	24.16	0.70
thymus, fetal, pool1	10043-101F7	74.60	35.64	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	246.38	101.85	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	168.19	72.36	1.26
thyroid, adult, pool1	10028-101E1	190.92	59.63	3.08
thyroid, fetal, donor1	10060-101H6	119.44	30.85	5.54
tongue epidermis (fungiform papillae), donor1	10288-104F9	73.91	6.16	0.00
tongue, adult	10203-103F5	87.45	34.89	1.16
tongue, fetal, donor1	10059-101H5	102.46	43.35	2.36
tonsil, adult, pool1	10047-101G2	96.77	39.37	0.80
trachea, adult, pool1	10029-101E2	100.94	38.12	0.57
trachea, fetal, donor1	10058-101H4	91.17	28.08	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	100.61	27.28	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	85.21	52.38	1.42
transitional-cell carcinoma cell line:JMSU1	10492-107B6	769.49	159.04	7.52
tridermal teratoma cell line:HGRT	10694-109G1	49.47	7.61	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	77.46	28.19	0.51
umbilical cord, fetal, donor1	10057-101H3	114.76	31.30	2.09
uterus, adult, pool1	10100-102D1	161.41	34.81	3.58
uterus, fetal, donor1	10055-101H1	116.21	29.69	0.51
vagina, adult	10204-103F6	58.16	13.57	0.00
vein, adult	10191-103E2	87.46	25.65	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	63.82	24.83	0.00